🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Evaluation of the Efficacy and Safety of APL-2 in Patients with Paroxysmal ...
Status
Completed
Location
University of Southern California
Start Date
2018-06-14
Trial ID
NCT03500549
Treatments Being Tested
Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing, inflammatory...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-09-03
Trial ID
NCT06673394
Treatments Being Tested
This study aims to evaluate the efficacy and safety of crovalimab in pediat...
Status
Active Not Recruiting
Location
Children's Hospital Colorado
Start Date
2021-11-17
Trial ID
NCT04958265
Treatments Being Tested
This study aims to evaluate the efficacy and safety of crovalimab in adult ...
Status
Active Not Recruiting
Location
Univ of CA San Francisco
Start Date
2021-10-22
Trial ID
NCT04861259
Treatments Being Tested
Long-term, multicenter, multinational, observational, registry of patients ...
Status
Recruiting
Location
Clinical Trial Site
Start Date
2024-02-01
Trial ID
NCT05966467
The complement system is an important component of the innate immune system...
Status
Active Not Recruiting
Location
Peking Union Medical College Hospital
Start Date
2025-04-15
Trial ID
NCT06848296
Treatments Being Tested
To assess the safety of intravitreal Zimura™ (complement factor C5 inhibito...
Status
Completed
Location
Retinal Research Institute
Start Date
2017-10-11
Trial ID
NCT03362190
Treatments Being Tested
The objectives of this study were to evaluate the safety and efficacy of Zi...
Status
Completed
Location
Multiple Locations
Start Date
2015-12-15
Trial ID
NCT02686658
Treatments Being Tested
Rationale: In COVID19 single-targeted immunomodulation, mostly via an IL-6 ...
Status
Completed
Location
Erasmus Medical Centre
Start Date
2020-03-02
Trial ID
NCT06311448
Treatments Being Tested
To asses the safety of intravitreal Zimura™ (complement factor C5 inhibitor...
Status
Withdrawn
Location
Retina Consultants of Hawaii
Start Date
2018-11
Trial ID
NCT03374670